Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Conditions: Childhood Hepatocellular Carcinoma; Childhood Malignant Liver Neoplasm; Elevated Alpha-Fetoprotein; Hepatoblastoma; SMARCB1 Gene Mutation Interventions: Drug: Carboplatin; Drug: Cisplatin; Drug: Doxorubicin; Drug: Etoposide; Drug: Fluorouracil; Drug: Gemcitabine; Drug: Irinotecan; Other: Laboratory Biomarker Analysis; Drug: Oxaliplatin; Other: Patient Observation; Drug: Sorafenib; Drug: Vincristine Sulfate Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Carcinoma | Chemotherapy | Children | Eloxatin | Hepatoblastoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Urology & Nephrology